← All trials
NCT01373567
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2010
- Primary completion
- Feb 1, 2012
- Completion date
- Jun 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 298
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- PiramalLead sponsor
- Dr. D. Y. Patil Dental College & HospitalOverall official - principal investigator
- Dr. Saple's clinic, 88, 3rd Lane, Hindu Colony, Near Bhagini Samaj, Dadar (East), Mumbai-400014Overall official - principal investigator
- Swarnkar Superspeciality Centre,84,Shreenagar Main,Regency Avenue,Ground Floor, Near Anand Bazar,IndoreOverall official - principal investigator
- M.S. Diabetes and Shirdi Skin care centre 6/1, 80 Feet Road, Opp. Krishna Sagar Hotel, Indiranagar, BangaloreOverall official - principal investigator
- Navprabhat Chambers,Opp, NagpurOverall official - principal investigator
- Renova Skin & Laser Clinic, JaipurOverall official - principal investigator
- Skin & Laser Center, New DelhiOverall official - principal investigator
- Skin Care Clinic, NagpurOverall official - principal investigator
- Postgraduate Institute of Medical Education and ResearchOverall official - principal investigator
- Sri Skin Care & Laser Clinic, Chowk-LucknowOverall official - principal investigator
- NKP Salve Institute and Lata Mangeshkar Hospital, NagpurOverall official - principal investigator
- PSG Hospital, PeelameduOverall official - principal investigator
- Sheth VS General HospitalOverall official - principal investigator
- Durgabai Deshmukh Hospital & Research CenterOverall official - principal investigator
- Medipoint Hospitals Pvt. Ltd.Overall official - principal investigator
- Lokmanya Tilak Municipal Medical CollegeOverall official - principal investigator
- Sai Life SciencesOverall official - principal investigator
- Bhatia Skin Center, Bima Nagar, IndoreOverall official - principal investigator
- Rajiv Gandhi University of Health SciencesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.